{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:48:35Z","timestamp":1789174115130,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T00:00:00Z","timestamp":1528761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00330-018-5425-z","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T14:12:14Z","timestamp":1528812734000},"page":"5356-5367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of contrast-enhanced FDG PET\/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma"],"prefix":"10.1007","volume":"28","author":[{"given":"Rania","family":"Refaat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Abd Alkhalik","family":"Basha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Sobhi","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha S.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"El Sammak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena Abd El Aziz","family":"El Sammak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Hesham Saleh","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla M.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somaia A.","family":"Saad El-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engi","family":"Elkholy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina R. D.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen A.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman F.","family":"Montasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,12]]},"reference":[{"key":"5425_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrgastro.2010.100","volume":"7","author":"JD Yang","year":"2010","unstructured":"Yang JD, Roberts LR (2010) Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 7:448\u2013458","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5425_CR2","unstructured":"Dhanasekaran R, Limaye A, Cabrera R (2012) Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med 4:19\u201337"},{"key":"5425_CR3","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.6004\/jnccn.2014.0113","volume":"12","author":"MA Prasad","year":"2014","unstructured":"Prasad MA, Kulik LM (2014) The role of bridge therapy prior to orthotopic liver transplantation. J Natl Compr Cancer Netw 12:1183\u20131191","journal-title":"J Natl Compr Cancer Netw"},{"key":"5425_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jceh.2013.02.246","volume":"3","author":"M Patily","year":"2013","unstructured":"Patily M, Sheth KA, Adarsh CK (2013) Elevated alpha fetoprotein, no hepatocellular carcinoma. J Clin Exp Hepatol 3:162\u2013164","journal-title":"J Clin Exp Hepatol"},{"key":"5425_CR5","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/hep.21408","volume":"44","author":"R Tateishi","year":"2006","unstructured":"Tateishi R, Shiina S, Yoshida H et al (2006) Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology 44:1518\u20131527","journal-title":"Hepatology"},{"key":"5425_CR6","unstructured":"Lind P, Igerc I, Beyer T, Nordin AJ, Reinprecht P, Hausegger K (2008) Advantages and limitations of FDG PET 16 in the follow-up of breast cancer. In: Bombardieri E, Gianni L, Bonadonna G (eds) Breast Cancer. Springer, Berlin, Heidelberg"},{"key":"5425_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/PPO.0000000000000105","volume":"21","author":"DY Lewis","year":"2015","unstructured":"Lewis DY, Soloviev D, Brindle KM (2015) Imaging tumor metabolism using positron emission tomography. Cancer J 21:129\u2013136","journal-title":"Cancer J"},{"key":"5425_CR8","doi-asserted-by":"crossref","unstructured":"Apostolova I, Wedel F, Brenner W (2016) Imaging of tumor metabolism using positron emission tomography (PET). Recent Results Cancer Res 207:177\u20131205","DOI":"10.1007\/978-3-319-42118-6_8"},{"key":"5425_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/MNM.0b013e3283622eef","volume":"34","author":"V Pant","year":"2013","unstructured":"Pant V, Sen IB, Soin AS (2013) Role of 18F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma. Nucl Med Commun 34:749\u2013757","journal-title":"Nucl Med Commun"},{"key":"5425_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/lt.24083","volume":"21","author":"Y Asman","year":"2015","unstructured":"Asman Y, Evenson AR, Even-Sapir E et al (2015) [18F] Fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma. Liver Transpl 21:572\u2013580","journal-title":"Liver Transpl"},{"key":"5425_CR11","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.3748\/wjg.v21.i10.3049","volume":"21","author":"O Detry","year":"2015","unstructured":"Detry O, Govaerts L, Deroover A et al (2015) Prognostic value of (18)F-FDG PET\/CT in liver transplantation for hepatocarcinoma. World J Gastroenterol 21:3049\u20133054","journal-title":"World J Gastroenterol"},{"key":"5425_CR12","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1097\/RLU.0000000000001040","volume":"41","author":"M Bailly","year":"2016","unstructured":"Bailly M, Venel Y, Orain I et al (2016) 18F-FDG PET in liver transplantation setting of hepatocellular carcinoma: predicting histology? Clin Nucl Med 41:e126\u2013e129","journal-title":"Clin Nucl Med"},{"issue":"47","key":"5425_CR13","doi-asserted-by":"publisher","first-page":"10406","DOI":"10.3748\/wjg.v22.i47.10406","volume":"22","author":"Yazan Abuodeh","year":"2016","unstructured":"Abuodeh Y, Naghavi AO, Ahmed KA et al (2016) Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization. World J Gastroenterol 22:10406\u201310414","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"5425_CR14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jhep.2015.11.033","volume":"64","author":"Geun Hong","year":"2016","unstructured":"Hong G, Suh KS, Suh SW et al (2016) Alpha-fetoprotein and 18F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation. J Hepatol 64:852\u2013859","journal-title":"Journal of Hepatology"},{"key":"5425_CR15","first-page":"2154","volume":"50","author":"LB Jeng","year":"2003","unstructured":"Jeng LB, Changlai SP, Shen YY et al (2003) Limited value of 18F-2-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers. Hepatogastroenterology 50:2154\u20132156","journal-title":"Hepatogastroenterology"},{"key":"5425_CR16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1600-6143.2008.02516.x","volume":"9","author":"A Kornberg","year":"2009","unstructured":"Kornberg A, Freesmeyer M, B\u00e4rthel E et al (2009) 18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients. Am J Transplant 9:592\u2013600","journal-title":"Am J Transplant"},{"key":"5425_CR17","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/hep.22693","volume":"49","author":"C Toso","year":"2009","unstructured":"Toso C, Asthana S, Bigam DL et al (2009) Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 49:832\u2013838","journal-title":"Hepatology"},{"key":"5425_CR18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/01.TP.0000152801.82734.74","volume":"79","author":"GC Sotiropoulos","year":"2005","unstructured":"Sotiropoulos GC, Malag\u00f3 M, Molmenti E et al (2005) Liver transplantation for hepatocellular carcinoma in cirrhosis: is clinical tumor classification before transplantation realistic? Transplantation 79:483\u2013487","journal-title":"Transplantation"},{"key":"5425_CR19","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1097\/01.tp.0000226069.66819.7e","volume":"81","author":"SA Shah","year":"2006","unstructured":"Shah SA, Tan JC, McGilvray ID et al (2006) Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation 81:1633\u20131639","journal-title":"Transplantation"},{"key":"5425_CR20","first-page":"368","volume":"36","author":"WW Lee","year":"2002","unstructured":"Lee WW, Ryu JS, Yang YJ et al (2002) Role of whole body FDG-PET in the diagnosis of hidden distant metastasis before liver transplantation in patients with primary liver cancer. Korean J Intern Med 36:368\u2013380","journal-title":"Korean J Intern Med"},{"key":"5425_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00535-004-1427-5","volume":"39","author":"M Sugiyama","year":"2004","unstructured":"Sugiyama M, Sakahara H, Torizuka T et al (2004) 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. J Gastroenterol 39:961\u2013968","journal-title":"J Gastroenterol"},{"key":"5425_CR22","first-page":"4719","volume":"25","author":"YK Chen","year":"2005","unstructured":"Chen YK, Hsieh DS, Liao CS et al (2005) Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence. Anticancer Res 25:4719\u20134725","journal-title":"Anticancer Res"},{"key":"5425_CR23","doi-asserted-by":"publisher","first-page":"W658","DOI":"10.2214\/AJR.10.6402","volume":"197","author":"DB Sneag","year":"2011","unstructured":"Sneag DB, Krajewski K, Giardino A et al (2011) Extrahepatic spread of hepatocellular carcinoma: spectrum of imaging findings. AJR Am J Roentegenol 197:W658\u2013W664","journal-title":"AJR Am J Roentegenol"},{"key":"5425_CR24","first-page":"1111","volume":"56","author":"AR Han","year":"2009","unstructured":"Han AR, Gwak GY, Choi MS et al (2009) The clinical value of 18F-FDG PET\/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom. Hepatogastroenterology 56:1111\u20131116","journal-title":"Hepatogastroenterology"},{"key":"5425_CR25","first-page":"1615","volume":"32","author":"Z Chen","year":"2012","unstructured":"Chen Z, Liang H, Zhang X et al (2012) Value of (18) F-FDG PET\/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein. Nan fang yi ke da xue xue bao 32:1615\u20131619","journal-title":"Nan fang yi ke da xue xue bao"},{"key":"5425_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/1751-2980.12064","volume":"14","author":"XY Wang","year":"2013","unstructured":"Wang XY, Chen D, Zhang XS et al (2013) Value of 18F-FDG-PET\/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: A comparative study with contrast-enhanced ultrasound. J Dig Dis 14:433\u2013438","journal-title":"J Dig Dis"},{"key":"5425_CR27","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00259-008-0743-z","volume":"35","author":"G Kong","year":"2008","unstructured":"Kong G, Jackson C, Koh DM et al (2008) The use of 18F-FDG PET\/CT in colorectal liver metastases\u2014comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging 35:1323\u20131329","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5425_CR28","first-page":"1241","volume":"47","author":"GL Cascini","year":"2006","unstructured":"Cascini GL, Avallone A, Delrio P et al (2006) 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 47:1241\u20131248","journal-title":"J Nucl Med"},{"key":"5425_CR29","first-page":"1469","volume":"18","author":"B Paudyal","year":"2007","unstructured":"Paudyal B, Oriuchi N, Paudyal P et al (2007) Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy. Oncol Rep 18:1469\u20131473","journal-title":"Oncol Rep"},{"key":"5425_CR30","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1200\/JCO.2002.12.134","volume":"20","author":"BS Langenhoff","year":"2002","unstructured":"Langenhoff BS, Oyen WJ, Jager GJ et al (2002) Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol 20:4453\u20134458","journal-title":"J Clin Oncol"},{"key":"5425_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/jso.10314","volume":"84","author":"V Donckier","year":"2003","unstructured":"Donckier V, Van Laethem JL, Goldman S et al (2003) [F-18] Fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 84:215\u2013223","journal-title":"J Surg Oncol"},{"key":"5425_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.crad.2014.09.020","volume":"70","author":"HJ Song","year":"2015","unstructured":"Song HJ, Cheng JY, Hu SL, Zhang GY, Fu Y, Zhang YJ (2015) Value of 18F-FDG PET\/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE. Clin Radiol 70:128\u2013137","journal-title":"Clin Radiol"},{"key":"5425_CR33","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s00261-016-0837-1","volume":"41","author":"EC Ehman","year":"2016","unstructured":"Ehman EC, Umetsu SE, Ohliger MA et al (2016) Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy. Abdom Radiol (NY) 41:2161\u20132168","journal-title":"Abdom Radiol (NY)"},{"key":"5425_CR34","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/j.gastro.2012.05.052","volume":"143","author":"C Duvoux","year":"2012","unstructured":"Duvoux C, Roudot-Thoraval F, Decaens T et al (2012) Liver transplantation for hepatocellular carcinoma: a model including \u03b1-fetoprotein improves the performance of Milan criteria. Gastroenterology 143:986\u2013994","journal-title":"Gastroenterology"},{"key":"5425_CR35","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jhep.2015.11.033","volume":"64","author":"G Hong","year":"2016","unstructured":"Hong G, Suh KS, Suh SW et al (2016) Alpha-fetoprotein and 18 F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation. J Hepatol 64:852\u2013859","journal-title":"J Hepatol"},{"key":"5425_CR36","doi-asserted-by":"publisher","first-page":"682","DOI":"10.2967\/jnumed.108.060574","volume":"50","author":"JW Lee","year":"2009","unstructured":"Lee JW, Paeng JC, Kang KW et al (2009) Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J Nucl Med 50:682\u2013867","journal-title":"J Nucl Med"},{"issue":"3","key":"5425_CR37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3904\/kjim.2015.30.3.308","volume":"30","author":"Min Jin Kim","year":"2015","unstructured":"Kim MJ, Kim YS, Cho YH et al (2015) Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolisation. Korean J Intern Med 30:308","journal-title":"The Korean Journal of Internal Medicine"},{"key":"5425_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5306\/wjco.v2.i5.229","volume":"2","author":"K Murakami","year":"2011","unstructured":"Murakami K (2011) FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations. World J Clin Oncol 2:229","journal-title":"World J Clin Oncol"},{"key":"5425_CR39","first-page":"213","volume":"44","author":"CL Ho","year":"2003","unstructured":"Ho CL, Simon CH, Yeung DW (2003) 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 44:213\u2013221","journal-title":"J Nucl Med"},{"key":"5425_CR40","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2967\/jnumed.108.052639","volume":"49","author":"Y Yamamoto","year":"2008","unstructured":"Yamamoto Y, Nishiyama Y, Kameyama R et al (2008) Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET. J Nucl Med 49:1245\u20131248","journal-title":"J Nucl Med"},{"key":"5425_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1158\/1078-0432.CCR-06-1357","volume":"13","author":"S Seo","year":"2007","unstructured":"Seo S, Hatano E, Higashi T et al (2007) Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res 13:427\u2013433","journal-title":"Clin Cancer Res"},{"key":"5425_CR42","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00259-013-2366-2","volume":"40","author":"MJ Song","year":"2013","unstructured":"Song MJ, Bae SH, Lee SW et al (2013) 18F-fluorodeoxyglucose PET\/CT predicts tumour progression after transarterial chemoembolisation in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 40:865\u2013873","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-018-5425-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5425-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5425-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T23:08:10Z","timestamp":1560294490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-018-5425-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5425"],"URL":"https:\/\/doi.org\/10.1007\/s00330-018-5425-z","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,12]]},"assertion":[{"value":"31 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Mohammad Abd Alkhalik Basha.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relevant conflicts of interest, and no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional review board approval was obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The corresponding author has wide statistical expertise","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"\u2022 Prospective\u2022 Diagnostic or prognostic study\u2022 Performed at multiple centres","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}